stockrow
Friday 6 November 2026
Export OPTH’s income statement to Excel — free account
Optimi Health Corp.
OPTH Healthcare Drug Manufacturers Specialty & Generic
Optimi Health Corp.’s revenue for fiscal 2025 (year ended September 2025) was $304,800.00, up 6.39% from fiscal 2024.
2.30
0.09
−3.77%
Follow OPTH
Alert me
| Mar '26 | Dec '25 | Jun '25 | Sep '24 | |
|---|---|---|---|---|
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(1.52) | 0.00 | 0.00 | — |
Free Cash Flow |
(4.89) | — | — | — |
Capital Expenditures |
(0.13) | — | — | — |
| Other line items | ||||
Cash ROIC |
(92.72%) | 0.00% | 0.00% | 0.00% |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.00 | — | — | — |
Depreciation/Fixed assets |
0.17 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
(0.09) | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(1.48) | 0.00 | 0.00 | — |
Capex per Share |
(0.04) | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | — | — | — |
Columns are period end dates · fundamentals updated 2 Nov 2026